Corcept Therapeutics (CORT) Amortizatization of Intangibles (2012 - 2025)

Corcept Therapeutics has disclosed Amortizatization of Intangibles across 13 years of filings, most recently posting $4.6 million for Q4 2025.

• Amortizatization of Intangibles for Q4 2025 came in at $4.6 million, up 2444.69% year-over-year; the trailing twelve-month figure through Dec 2025 was $5.1 million (up 843.25% YoY), and the FY2025 annual result was $5.1 million, up 843.25% from the prior year.
• Amortizatization of Intangibles came in at $4.6 million for Q4 2025 at Corcept Therapeutics, up from $188000.0 in the prior quarter.
• In the past five years, Amortizatization of Intangibles ranged from a high of $4.6 million in Q4 2025 to a low of -$3.0 million in Q4 2022.
• The 5-year median for Amortizatization of Intangibles is $185500.0 (2025), against an average of $378800.0.
• Across the five-year window, Amortizatization of Intangibles tumbled 691.73% in 2022 and jumped 2444.69% in 2025, its largest moves.
• Corcept Therapeutics' Amortizatization of Intangibles stood at $508000.0 in 2021, then sank by 691.73% to -$3.0 million in 2022, then soared by 101.93% to $58000.0 in 2023, then jumped by 208.62% to $179000.0 in 2024, then surged by 2444.69% to $4.6 million in 2025.
• The last three Amortizatization of Intangibles figures came in at $4.6 million (Q4 2025), $188000.0 (Q3 2025), and $183000.0 (Q2 2025), per Business Quant data.